Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+39.27%
|
$336,000
$42.15 P/Share
|
|
Apr 10
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+0.28%
|
$12,936
$231.77 P/Share
|
|
Apr 10
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+2.68%
|
$14,784
$231.77 P/Share
|
|
Apr 10
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+9.51%
|
$14,784
$231.77 P/Share
|
|
Apr 10
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+2.11%
|
$21,021
$231.77 P/Share
|
|
Apr 10
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+11.87%
|
$13,629
$231.77 P/Share
|
|
Apr 10
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56
+26.05%
|
$12,936
$231.77 P/Share
|
|
Mar 17
2023
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+25.78%
|
$0
$0.94 P/Share
|
|
Mar 08
2023
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+24.56%
|
$8,774
$2.07 P/Share
|
|
Mar 01
2023
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-43.21%
|
$54,230,000
$5423.45 P/Share
|
|
Mar 01
2023
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+49.25%
|
$0
$0.94 P/Share
|
|
Feb 27
2023
|
Steven Jandrich VP, Human Resources |
BUY
Bona fide gift
|
Indirect |
128
+21.12%
|
-
|
|
Feb 27
2023
|
Steven Jandrich VP, Human Resources |
SELL
Bona fide gift
|
Direct |
128
-2.85%
|
-
|
|
Feb 24
2023
|
Steven Jandrich VP, Human Resources |
BUY
Bona fide gift
|
Indirect |
128
+21.12%
|
-
|
|
Feb 24
2023
|
Steven Jandrich VP, Human Resources |
SELL
Bona fide gift
|
Direct |
256
-2.73%
|
-
|
|
Feb 16
2023
|
Philip Ebeling Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,000
-96.65%
|
$1,925,000
$275.0 P/Share
|
|
Feb 16
2023
|
Philip Ebeling Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+49.15%
|
$1,358,000
$194.82 P/Share
|
|
Feb 15
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
11,715
-39.57%
|
$3,221,625
$275.17 P/Share
|
|
Feb 14
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
20,138
-21.14%
|
$5,537,950
$275.82 P/Share
|
|
Feb 13
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
2,619
-21.21%
|
$720,225
$275.05 P/Share
|
|
Feb 09
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
7,028
-36.27%
|
$1,932,700
$275.12 P/Share
|
|
Feb 08
2023
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
3,500
-15.3%
|
$962,500
$275.0 P/Share
|
|
Feb 08
2023
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,500
-11.38%
|
$667,500
$267.5 P/Share
|
|
Feb 06
2023
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,500
-6.32%
|
$875,000
$250.36 P/Share
|
|
Jan 29
2023
|
Bryan K Phillips Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-9.47%
|
$51,865
$253.24 P/Share
|
|
Jan 25
2023
|
Richard Buchholz Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,100
+4.86%
|
$250,100
$41.18 P/Share
|
|
Jan 23
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+9.51%
|
$0
$0.94 P/Share
|
|
Jan 13
2023
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,977
-25.83%
|
$2,994,250
$250.03 P/Share
|
|
Jan 11
2023
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
523
-1.12%
|
$130,750
$250.0 P/Share
|
|
Jan 10
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
60
+2.59%
|
$14,880
$248.31 P/Share
|
|
Jan 10
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+12.67%
|
$13,640
$248.31 P/Share
|
|
Jan 10
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
60
+9.92%
|
$14,880
$248.31 P/Share
|
|
Jan 10
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+2.01%
|
$21,080
$248.31 P/Share
|
|
Jan 10
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.27%
|
$12,896
$248.31 P/Share
|
|
Jan 10
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52
+33.55%
|
$12,896
$248.31 P/Share
|
|
Jan 05
2023
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
400
+7.55%
|
-
|
|
Jan 05
2023
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
400
-0.85%
|
-
|
|
Jan 03
2023
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,170
-7.2%
|
$299,520
$256.0 P/Share
|
|
Jan 03
2023
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-46.23%
|
$2,520,000
$252.95 P/Share
|
|
Jan 03
2023
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+49.25%
|
$0
$0.94 P/Share
|
|
Dec 19
2022
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
678
-4.01%
|
$170,178
$251.72 P/Share
|
|
Dec 16
2022
|
Marilyn C Nelson Director |
SELL
Open market or private sale
|
Indirect |
25,211
-7.44%
|
$6,151,484
$244.63 P/Share
|
|
Dec 05
2022
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,333
-46.57%
|
$2,438,588
$236.76 P/Share
|
|
Dec 02
2022
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,333
+49.32%
|
$0
$0.94 P/Share
|
|
Nov 21
2022
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Bona fide gift
|
Direct |
24,115
+17.52%
|
-
|
|
Nov 21
2022
|
Timothy P. Herbert CEO, President & Chairperson |
BUY
Bona fide gift
|
Indirect |
12,231
+9.25%
|
-
|
|
Nov 21
2022
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Indirect |
36,346
-100.0%
|
-
|
|
Nov 18
2022
|
Philip Ebeling Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
167
-40.73%
|
-
|
|
Nov 11
2022
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
9,217
-57.05%
|
$2,036,957
$221.58 P/Share
|
|
Nov 11
2022
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,277
+37.5%
|
$0
$0.94 P/Share
|